期刊文献+

糖原累积病Ⅲa型一家系两例患儿的分子诊断研究 被引量:5

Identification of a novel mutation of AGL gene in two siblings affected with glycogen storage disease typeⅢ a
原文传递
导出
摘要 目的研究糖原累积病IIIa型一家系AGL基因突变特点。方法分析一家系两例疑诊糖原累积病IIIa型患儿的临床资料。分别采集研究对象外周抗凝血标本,提取基因组DNA,然后对AGL基因所有外显子及其侧翼序列进行Sanger测序,以寻找致病突变。然后,通过对75名健康志愿者AGL基因相应外显子的Sanger测序,调查新突变的人群分布频率。结果该家系中姐弟二人均以低血糖及肝脏增大为主要临床特征,伴转氨酶及肌酶明显升高。AGL基因分析显示两患儿均为突变c.1735+1G〉T和C.9591G〉C的复合杂合子,后一个突变未见文献报道,在正常人群中频率小于1%。结论通过AGL基因分析,结合临床表现,该家系中姐弟二人均确诊为糖原累积病IIIa型患者。新突变c.959—1G〉C的识别扩展了AGL基因突变谱,同时为患儿分子诊断和家系遗传咨询提供了实验依据。 Objective To detect potential mutation of the AGL gene in two siblings affected with glycogen storage disease type []] a. Methods Clinical data of the two siblings was collected and analyzed. Genomic DNA was extracted from peripheral venous blood samples from the patients and their parents. All exons and their flanking sequences of the AGL gene were subjected to PCR amplification and Sanger sequencing. Suspected mutation was verified in 75 healthy controls. Results The main clinical features of the two siblings included hypoglycemia and hepatomegaly, along with markedly elevated liver and myocardial enzymes. Genetic analysis revealed that both siblings harbored compound heterozygous mutations c. 1735- 1G〉T and c. 959-1G〉C of the AGL gene. Among these, the splicing mutation c. 959 1G〉C was a novel one with an allele frequency of 〈1 %. Conclusion Based on their clinical features and genetic analysis, the siblings were diagnosed with glycogen storage disease type Ⅲ a. The c. 959 1G〉C has enriched the spectrum of AGL gene mutations.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2017年第4期499-503,共5页 Chinese Journal of Medical Genetics
基金 暨南大学附属第一医院科研培育专项基金(2014208)
关键词 糖原累积病 AGL基因 剪接位点突变 左心室肥厚 Glycogen storage disease AC-L gene Splice-site variant Left ventricularhypertrophy
  • 相关文献

参考文献3

二级参考文献51

  • 1庄太凤,邱正庆,魏珉,黄尚志.糖原贮积症Ⅲ型基因突变的初步研究[J].中华儿科杂志,2005,43(2):85-88. 被引量:4
  • 2Shin YS. Diagnosis of glycogen storage disease. J Inherit Metab Dis, 1990, 13:419-434.
  • 3Zschocke J, Hoffmann GF. Vademecum Metabolicum Manual of Metabolic Paediatrics. London : Schattauer, 1999:25-26.
  • 4Maire I, Baussan C, Moatti N, et al. Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem, 1991, 24 : 169-178.
  • 5Bhuiyan J, Al Odaib AN, Ozand PT. A simple, rapid test for the differential diagnosis of glycogen storage disease type 3. Clin Chim Acta, 2003, 335:21-26.
  • 6Bao Y, Dawson TL Jr, Chen YT. Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5'-prime flanking region. Genomics, 1996, 38 : 155-165.
  • 7Santer R, Kinner M, Steuerwald U, et al. Molecular genetic basis and prevalence of glycogen storage disease type Ⅲ a in the Faroe Islands. Eur J Hum Genet, 2001, 9:388-391.
  • 8Parvari R, Moses S, Shen J, et al. A single-base deletion in the 3' -coding region of glycogen debranching enzyme is prevalent in glycogen storage disease type Ⅲ A in a population of North African Jewish patients. Eur J Hum Genet, 1997, 5:266-270.
  • 9Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type Ⅲ Curr Mol Med, 2002, 2:167-175.
  • 10Lam CW, Lee AT, Lam YY, et al. DNA-based subtyping of glycogen storage disease type Ⅲ: mutation and haplotype analysis of the AGL gene in Chinese. Mol Genet Metab, 2004, 83:271-275.

共引文献8

同被引文献17

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部